Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Neurology
|
March 5, 2008
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence
A D Norden, G S Young, K Setayesh, et al.
British Journal of Cancer
|
June 16, 2011
Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma
R S Bhatt, A J Zurita, A O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
Physical Review Letters
|
December 24, 2019
Large Collective Lamb Shift of Two Distant Superconducting Artificial Atoms
P Y Wen, K-T Lin, A F Kockum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 1998
5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats
A I Kassis, P Y Wen, A D Van den Abbeele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, R J Kreitman, Z A Wainberg, et al.
Physical Review Letters
|
September 10, 2025
Group Delay Controlled by the Decoherence of a Single Artificial Atom
Y-T Cheng, K-M Hsieh, B-Y Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor
A I Kassis, S S Tumeh, P Y Wen, et al.
Journal of Neuro-Oncology
|
October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J Drappatz, E Q Lee, S Hammond, et al.
The Lancet. Oncology
|
April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M J van den Bent, J S Wefel, D Schiff, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Neurology
|
March 5, 2008
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence
A D Norden, G S Young, K Setayesh, et al.
British Journal of Cancer
|
June 16, 2011
Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma
R S Bhatt, A J Zurita, A O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
Physical Review Letters
|
December 24, 2019
Large Collective Lamb Shift of Two Distant Superconducting Artificial Atoms
P Y Wen, K-T Lin, A F Kockum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 21, 1998
5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats
A I Kassis, P Y Wen, A D Van den Abbeele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, R J Kreitman, Z A Wainberg, et al.
Physical Review Letters
|
September 10, 2025
Group Delay Controlled by the Decoherence of a Single Artificial Atom
Y-T Cheng, K-M Hsieh, B-Y Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor
A I Kassis, S S Tumeh, P Y Wen, et al.
Journal of Neuro-Oncology
|
October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J Drappatz, E Q Lee, S Hammond, et al.
The Lancet. Oncology
|
April 9, 2011
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M J van den Bent, J S Wefel, D Schiff, et al.
Page
of 6